2022 Congenital Syphilis Update, Information and Recommendations for Providers
Date: July 12, 2022
Public Health Message Type: Advisory, Update
Counties Effected: All
Intended Audience: Healthcare providers, All public health partners, local health departments
Contact: Amelia Hamarman, STD Program email@example.com
Message: New Jersey continues to see alarming increases in cases of early syphilis, syphilis in women and congenital syphilis. In response, NJ DOH is recommending additional testing precautions for pregnant patients throughout New Jersey.
Total reported syphilis cases have increased by 63% in New Jersey since 2019. For infectious stages of syphilis (primary (e.g., chancre) and secondary (e.g., rash)), reported cases have increased 46%. Cases of congenital syphilis have increased from 15 cases in 2019 to 49 cases in 2021.
N.J.A.C.26:4-49.4 requires a physician who treats a patient for pregnancy to conduct syphilis testing at the first prenatal visit and at the time of delivery. The NJ DOH supports the joint recommendation from the Centers for Disease Control and Prevention (CDC) , the American College of Obstetricians and Gynecologists (ACOG) and the American Academy of Pediatrics (AAP) for additional syphilis screening early in the third trimester for patients at increased risk for syphilis, which includes those living in higher-prevalence geographic areas. Given the historical increases in syphilis cases throughout New Jersey, the NJDOH is recommending additional third trimester screening for all pregnant patients. Specifically, NJ DOH is recommending that physicians offer syphilis testing to pregnant patients:
· At their first prenatal visit
· Early in the third trimester of pregnancy (about 28 weeks gestation)
· At time of delivery of an infant
· At time of fetal death after 20 weeks gestation
A complete syphilis test includes BOTH an RPR and a specific treponemal (e.g. FTA. TPPA) test. Please work with your IT team to ensure that EHR lab orders are coded properly to include “reflex to confirmatory”. Delaying confirmatory testing can create delays to treatment as well as increased spread of disease. For assistance interpreting results, reporting treatment, or other concerns, please call the NJ DOH STD Program at 609-826-4869.
Resources and Information:
Syphilis testing and treatment https://www.cdc.gov/std/treatment/default.htm
Syphilis Pocket Guide for Providers https://www.cdc.gov/std/syphilis/Syphilis-Pocket-Guide-FINAL-508.pdf
CDC Congenital Syphilis Page https://www.cdc.gov/std/syphilis/stdfact-congenital-syphilis.htm
NJDOH Congenital Syphilis Site http://www.nj.gov/health/hivstdtb/stds/congenital_syphilis.shtml
NJ STD Reporting Requirements http://www.nj.gov/health/hivstdtb/stds/
This information has been broadcast to: Local Media; Blood Banks; Community Health Centers (FQHCs); Emergency Medical Services / First Responders; EMS Council; Long-term Care; Health Care Facilities / Other; Health Care Organizations; Health Care Providers; Hospital Staff Directory; Hospital CEOs; Hospital Emerg Preparedness Coords; Hospital ER Medical Directors; Hospital Infection Control Practitioners; Hospital Medical Directors; Hospital Nursing Directors; Hospital Security Directors; ICU Administrator; Lab Director; Hospitals / Acute Care; Hospitals / Other; Hospitals / Veterans; Labs / Non-Sentinel; Labs / Sentinel; Local Boards of Health; NJDOH Staff; NJLINCS and Local Contacts; NJLINCS Community; Public Health Associations; Public Health Council; Public Health Sector